Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Morgese
Observed names:
F. Morgese,
MORGESE, FRANCESCA,
Morgese,
Morgese, Francesca
Institution:
Azienda Ospedaliero-Universitaria delle Marche
Observed institutions:
Marche Polytechnic University,
Azienda Ospedaliero-Universitaria delle Marche,
IRCCS Ospedale San Raffaele,
University of Southampton,
University of Bari Aldo Moro
ORCID:
0000-0002-0994-3713
Observed ORCID:
0000-0002-0994-3713
OpenAlex ID:
A5075790876
Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
2020
·
Rossana Berardi
, Francesca Morgese
, et al.
·
Cancer Management and Research
·
194
Role of maspin in cancer
2013
·
Rossana Berardi
, Francesca Morgese
, et al.
·
Clinical and Translational Medicine
·
135
PDF
Hyponatremia in cancer patients: Time for a new approach
2016
·
Rossana Berardi
, Silvia Rinaldi
, et al.
·
Critical Reviews in Oncology/Hematology
·
78
Electrolyte disorders in cancer patients: a systematic review
2019
·
Rossana Berardi
, Mariangela Torniai
, et al.
·
Journal of Cancer Metastasis and Treatment
·
72
PDF
Gender Differences and Outcomes in Melanoma Patients
2020
·
Francesca Morgese
, Caterina Sampaolesi
, et al.
·
Oncology and Therapy
·
66
PDF
Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
2021
·
Valeria Cognigni
, Nicoletta Ranallo
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
64
PDF
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management
2020
·
Giulia Mentrasti
, Laura Scortichini
, et al.
·
Therapeutics and Clinical Risk Management
·
62
PDF
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients
2015
·
R. Berardi
, M. Caramanti
, et al.
·
Supportive Care in Cancer
·
61
Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
2016
·
Rossana Berardi
, Matteo Santoni
, et al.
·
PLoS ONE
·
59
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
2016
·
Rossana Berardi
, Silvia Rinaldi
, et al.
·
Oncotarget
·
54
PDF
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
2016
·
Rossana Berardi
, Matteo Santoni
, et al.
·
Oncotarget
·
52
PDF
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
2016
·
Rossana Berardi
, Francesca Morgese
, et al.
·
Oncotarget
·
48
PDF
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer
2019
·
Rossana Berardi
, Matteo Santoni
, et al.
·
Annals of Translational Medicine
·
43
PDF
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
2017
·
Vera Hirsh
, Sandro Pignata
, et al.
·
Journal of Translational Medicine
·
43
PDF
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
2020
·
Laura Ridolfi
, Francesco De Rosa
, et al.
·
Journal of Geriatric Oncology
·
40
High CTLA-4 expression correlates with poor prognosis in thymoma patients
2018
·
Giorgio Santoni
, Consuelo Amantini
, et al.
·
Oncotarget
·
39
PDF
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma
2014
·
R. Berardi
, M. Caramanti
, et al.
·
Supportive Care in Cancer
·
38
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis
2020
·
Luca Cantini
, Filippo Merloni
, et al.
·
Critical Reviews in Oncology/Hematology
·
34
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy—A literature review
2015
·
Rossana Berardi
, Silvia Rinaldi
, et al.
·
Critical Reviews in Oncology/Hematology
·
33
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival
2020
·
Francesco Mannavola
, Mario Mandala
, et al.
·
Frontiers in Oncology
·
29
PDF
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
2013
·
Rossana Berardi
, M Santoni
, et al.
·
OncoTargets and Therapy
·
26
PDF
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
2022
·
W. Bruno
, B. Dalmasso
, et al.
·
ESMO Open
·
25
PDF
Systemic treatment for lung carcinoids: from bench to bedside
2019
·
Mariangela Torniai
, Laura Scortichini
, et al.
·
Clinical and Translational Medicine
·
25
PDF
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
2018
·
S. Rinaldi
, M. Santoni
, et al.
·
Supportive Care in Cancer
·
25
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023
·
Marco Rubatto
, Paolo Fava
, et al.
·
European Journal of Cancer
·
23
Show more works
View as search
Works count:
88
Citation count:
1,616
H-index:
24
I10-index:
35
Year
Topic
Type